Hier finden Sie grundlegende Angaben zu klinischen Studien des Comprehensice Cancer Centers Mainfranken (CCC MF)
Filter aktiv
Seite 24 - Studien 231 bis 240 von insgesamt 320
- Rekrutierung läuft2- and 5-year neuropsychological follow-up of young children with medulloblastoma, CNS-PNET and ependymoma treated within the prospective multicenter trial HIT 2000 SKK
Geplante Laufzeit: 01.07.2013 - 31.03.2017 - Rekrutierung läuftNon interventional study of melphalan flufenamide in combination with dexamethasone in patientnts with relapsed and or refractory MM according to the approved labelDRKS00033264
- Rekrutierung läuftTreatment and outcome of patients with advanced breast cancer: clinical research platform for real world data (OPAL) IOM-100361Indikationen
- Rekrutierung läuftA Phase III, double-blind, placebo-controlled, Randomised, Multicentre, International Study of Durvalumab Plus Oleclumab and Durvalumab Plus Monalizumab in Patients With Locally Advanced (Stage III), Unresectable Non-small Cell Lung Cancer (NSCLC) Who Have Not Progressed Following Definitive, Platinum-Based Concurrent Chemoradiation Therapy (PACIFIC-9)Molekulare Marker
- Rekrutierung läuft
A Phase 2, Open-Label, Parallel Cohort Study of Subcutaneous Amivantamab in Multiple Regimens in Patients with Advanced or Metastatic Solid Tumors including EGFR-mutated Non-Small Cell Lung Cancer [CR109264]
Molekulare Marker - Rekrutierung läuftPatientendatenintegrationsplattform der Pancreatic Cancer Alliance Bavaria (PCAB)
- Rekrutierung läuftProstate Cancer Outcomes – Compare & Reduce Variation in DKG - zertifizierten ProstatakrebszentrenDRKS00010774Indikationen
- Rekrutierung läuftPEARL-StudiePrävention von Darmkrebs bei jungen Erwachsenen zwischen 18-49 Jahren
- Rekrutierung läuftAn Epidemiological, Prospective Cohort Study to Generate Real-world Evidence in Patients with HR*/HER2- Advanced Breast Cancer Treated in the First-line Setting as per Current Standard of Care with an Endocrine-based Palbociclib Combination TherapyIndikationen
- Rekrutierung läuftPERSUASIONNew Prospective Expanded German Registry of Incidental Gallbladder Carcinoma (PERSUASION) a permanent platform including all kind of biliary tract cancers (BTC)